Show simple item record

dc.creatorNikolić, Ivana
dc.creatorVujičić, Milica
dc.creatorStojanović, Ivana D.
dc.creatorStošić-Grujičić, Stanislava
dc.creatorSaksida, Tamara
dc.date.accessioned2016-05-23T11:00:29Z
dc.date.issued2014
dc.identifier.issn1365-3083
dc.identifier.urihttp://ibiss-r.rcub.bg.ac.rs/123456789/2183
dc.description.abstractCarbon monoxide (CO) is endogenously produced by haeme oxygenase-1 and has profound effects on intracellular signalling processes, generating anti-inflammatory, antiproliferative and antiapoptotic effects. A boron-containing compound CORM-A1 is capable of releasing CO in such a way to mimic physiological functions of haeme oxygenase-1. Considering the importance of Th1/Th17 versus Th2 balance in the final outcome of immune and inflammatory responses in this study we focused on immune-modulatory effects of CORM-A1 on murine lymph node-derived T cells in vitro and its influence on T-cell proliferation, activation and differentiation. Anti-CD3/CD28 antibody-triggered lymph node cells proliferation remained unaffected after 24-hour CORM-A1 treatment, as well as the expression of the early activation marker CD25. However, CORM-A1 successfully reduced the secretion of the two representative pro-inflammatory cytokines, IFN-gamma and IL-17, while the secretion of anti-inflammatory cytokine IL-4 remained unchanged. Furthermore, CORM-A1 efficiently reduced the percentage of CD4(+)IFN-gamma(+) and CD4(+)IL-17(+) cells, whereas CD4(+)IL-4(+) cell population increased after treatment. Also, CORM-A1 significantly reduced expression of transcription factor ROR gamma T, necessary for Th17 development, but the expression of Th1-related and Th2-related transcription factors (T-bet and GATA-3, respectively) remained unchanged. In conclusion, our findings indicate that CO has anti-inflammatory role through the regulation of balance between pro-inflammatory Th1/Th17 and anti-inflammatory Th2 cells. Observed immunomodulatory effects of CORM-A1 could be useful for developing novel therapeutic approaches in managing Th1/Th17-mediated immune disorders.
dc.description.sponsorshipEFSD New Horizons Collaborative Research Initiative; Ministry of Education, Science and Technological Development, Republic of Serbia {[}173013]
dc.languageEnglish
dc.sourceScandinavian Journal of Immunology
dc.titleCarbon Monoxide-Releasing Molecule-A1 Inhibits Th1/Th17 and Stimulates Th2 Differentiation In vitro
dc.typearticle
dcterms.abstractСаксида, Тамара; Вујичић, Милица; Стошић-Грујичић, Станислава Д.; Николић, Ивана; Стојановиц, И.;
dc.citation.issue2
dc.citation.volume80
dc.identifier.doi10.1111/sji.12189
dc.identifier.scopus2-s2.0-84903906605
dc.identifier.wos000339431700003
dc.citation.spage95
dc.citation.epage100
dc.type.versionpublishedVersionen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record